Plerixafor — CAS 110078-46-1

Plerixafor is a cxcr4 antagonist manufactured by Mediocon Inc at its GMP-certified facility in Aurangabad, Maharashtra, India. We supply Plerixafor in IP / BP / USP grade to pharmaceutical manufacturers worldwide, with full documentation including Certificate of Analysis, MSDS, and Certificate of Origin. CAS No: 110078-46-1.

• Stem cell mobilization for autologous transplantation in multiple myeloma and NHL
• Used in combination with G-CSF to mobilize hematopoietic stem cells
• CXCR4 chemokine receptor antagonist for stem cell harvest optimization
• Investigational use in HIV treatment and WHIM syndrome

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support